Objectives: Determine imaging characteristics specific to epithelioid (eMPM), sarcomatoid (sMPM), and biphasic (bMPM) subtypes of malignant pleural mesothelioma (MPM) on computed tomography.
M alignant pleural mesothelioma (MPM) is a rare neoplasm with an annual incidence in the United States of 2500 cases. 1 Nevertheless, it is the most common primary malignancy of the pleura and has been increasing in incidence in recent decades in the United States and worldwide, related to an increase in asbestos exposure in industrialized countries. 2 Prognosis remains overall poor, with a median survival of 9 to 17 months. 1 Multimodality therapy comprising surgery and subsequent chemoradiation can prolong survival. 3, 4 Histologic subtype is a strong prognostic factor and key for treatment planning. Malignant pleural mesothelioma is divided by cellular morphology into 3 broad histologic subtypes: epithelioid, sarcomatoid, and biphasic/mixed. Epithelioid MPM (eMPM) is the most common subtype, representing approximately 70% of all cases.
Sarcomatoid MPM (sMPM) accounts for 10% of cases, and biphasic MPM (bMPM), which consists of a mixture of at least 10% of both epithelioid and sarcomatoid components, accounts for the remainder. 5 Epithelioid histology has the longest survival, sarcomatoid has the worst, and biphasic has an intermediate survival. 6 One 2015 study of 1183 patients with MPM found a median survival of 14, 10, and 4 months in the epithelioid, biphasic, and sarcomatoid groups, respectively. [7] [8] [9] Computed tomography (CT) is the primary modality for identifying and evaluating patients with MPM. The majority of patients demonstrate a unilateral pleural effusion (74%) and pleural thickening (92%). 10 Pleural thickening that is nodular, lobular, circumferential, or greater than 1 cm in thickness is particularly concerning for MPM. 1, 11 Additional common imaging findings detectable by CT include ipsilateral volume loss, invasion of the pericardium, mediastinum, diaphragm or chest wall, intrathoracic nodal involvement, and pulmonary and distant metastases. 1, 12 Local tumor extension into the chest wall, diaphragm, mediastinum, or spine often manifests as obscured fat planes and precludes surgical resection.
In 1981, Alexander et al 13 published one of the earliest papers describing the CT findings of mesothelioma [Alexander] . To this date, however, given the rarity of the disease, no large series exists describing the CT appearance of different subtypes of mesothelioma. Given that histological subtype consistently correlates with overall survival, finding a reliable way to distinguish these subtypes in patients with MPM would be extremely helpful in triaging patients, particularly those who have diagnoses made on small biopsies (eg, fine needle biopsy or pleural fluid cytology) rather than surgical biopsies. Surgeons and oncologists can then use this information to plan management, stratify patients in clinical trials, and help families and patients make informed decisions. Three identified studies address whether CT characteristics can be used to reliably distinguish the histologic subtypes of mesothelioma, but all have conflicting results. [14] [15] [16] We present a retrospective study similarly analyzing CT features of these distinct subtypes to identify any potential differentiating characteristics. The current study uniquely uses pathology predominantly from surgical resection (pleurectomy decortication, extrapleural pneumonectomy, exploratory thoracotomy, or wedge resection or lobectomy) with a small percentage from video-assisted thoracoscopic surgery biopsy, thus providing a uniform and reliable classification of all patients. We aim to provide some clarity on the issue given the conflicting results of prior research.
MATERIAL AND METHODS

Imaging Review
Our institutional review board approved this retrospective study and waived the requirement for informed consent. This study was Health Insurance Portability and Accountability compliant. Consecutive patients were identified from a prospectively maintained The images were reviewed on a picture archiving and communications system (GE PACS; Waukesha, Wis). Many of the patients had been referred from outside institutions to our tertiary referral center after initial imaging elsewhere; therefore, CT protocols varied slightly. Initial staging CT scans were performed on a range of multidetector CT scanners, with slice thickness varying from 1.25 to 7.5 mm, with the majority having a slice thickness of 5 mm (n = 111, 89%). The majority of cases were only available in the axial plane (n = 73, 58%), whereas the remainder had coronal or sagittal reformats available for review (n = 52, 42%). All patients had contrast-enhanced CT scans.
All imaging was independently reviewed by 2 trainees, postgraduate years 5 and 8, blinded to the patient's pathology. Discordant findings were reviewed by 2 thoracic attendings and final assessment determined by consensus.
Each CT was assessed for primary affected side, presence of volume loss, pleural calcifications, pleural effusion, pulmonary nodules, and thoracic lymphadenopathy. Pleural thickening was graded as continuous or discontinuous and lobulated or smooth (Figs. 1-2). Maximum pleural thickness was measured in the upper lung (defined as above the carina), lower lung (defined as below the carina), and along the diaphragm, also noting the location of the maximum pleural thickening at each level (paramediastinal, paraspinal, or lateral). Pleural thickening was measured on the lung windows. Soft tissues windows were used for confirmation and to ensure the area of suspected pleural thickening was soft tissue rather than fluid density. Volume loss was assessed subjectively by the radiologist. If a positron emission tomography (PET)-CT or CT of the abdomen and pelvis was available within 1 month of the index scan, the imaging and report, if available, were reviewed to assess for distant metastases.
Pathology Review
Pathologic diagnosis was obtained from the surgical database. All surgery was performed at the same tertiary care center and pathology reviewed by in-house pathologists who specialized in thoracic malignancies. 
Statistics
Associations between pathologic subtypes and categorical features were assessed using the Fisher exact test, whereas the Kruskal-Wallis test was used to test for differences in continuous CT characteristics between the subtypes. P values of less than 0.05 were considered significant.
RESULTS
Two hundred eighty-nine subjects with MPM were identified from a surgical database spanning 10 years. Seventy-five subjects were excluded because of lack of a preoperative contrastenhanced CT scan available in our system (50) or only available as a hard copy (25). Twenty-nine subjects were excluded because of greater than 90 days between the index preoperative contrastenhanced CT scan and surgery. Fifty-five subjects were removed because of evidence of prior talc pleurodesis, subsequently confirmed in the medical record, which was felt would affect CT imaging characteristics. Five subjects were removed from the study because of final pathology yielding benign (2), nonclassifiable (2), or nonmesothelioma (1) There was no significant difference in degree, location, or appearance of pleural thickening seen on CT between the 3 histologic subtypes (Table 1 ). In evaluation of additional ancillary characteristics, there was no significant difference between histologic subtypes (Table 2, Figs. 3-4) . The bMPM and sMPM were more likely to demonstrate calcified pleural plaques and sMPM with internal mammary nodes with P values approaching significance (P = 0.075 and 0.071, respectively). Calcified plaques were seen in 24 of 97 (25%) eMPM, 7 of 17 (41%) bMPM, and 6 of 11 (55%) sMPM. Internal mammary nodes were seen in 21 of 97 (22%) eMPM, 4 of 17 (24%) bMPM, and 6 of 11 (55%) sMPM.
Although imaging correlates were not statistically significantly associated with the 3 histologic subtypes, using the binary categorization from the Cancer and Leukemia Group B prognostic index of epithelioid versus nonepithelioid subtypes, repeat analysis was performed comparing epithelioid MPM and all nonepithelioid MPM (grouping biphasic and sarcomatoid together). 8 In this analysis, bMPM and sMPM combined were more likely to have calcified plaques than eMPM (P = 0.035). When stratified analysis with 50/97 (52%) of eMPM (P = 0.045). There was no significant difference in characterization of pleural thickening or other ancillary findings on CT.
DISCUSSION
Given the different management strategies between histologic subtypes of MPM and consistent correlation of histologic subtype with overall survival, finding a reliable way to distinguish these subtypes would be extremely helpful in triaging patients, particularly those who have diagnoses made on small biopsies (eg, fine needle biopsy or pleural fluid cytology) rather than surgical biopsies. Identifying eMPM from nonepithelioid subtypes would prove most useful because eMPM has the best prognosis and is the most appropriate for surgery. This would give surgeons and oncologists more confidence in recommending aggressive trimodality therapy for these patients and diverting higher risk patients to more experimental interventions. The CT imaging is the primary modality for identifying and evaluating patients with MPM and would be the easiest noninvasive means to classify subtypes. However, prior studies have shown conflicting results regarding which CT characteristics could be used for subtype differentiation.
In 2000, Senyigit et al 14 evaluated the imaging features of 117 patients with mesothelioma and found that sarcomatoid subtype was more likely to involve the mediastinal pleura, interlobar fissures, and lung parenchyma. In 2009, Seely et al 15 assessed the CT appearances of 92 patients with mesothelioma, composed of 72 (78%) epithelioid, 15 sarcomatoid (16%), and 5 (5%) biphasic type. The only statistically significant difference between the groups was the more frequent presence of ipsilateral volume loss in sarcomatoid and biphasic mesothelioma. 15 However, in 2015, Dickens et al 16 performed a similar study in which they assessed 139 patients with mesothelioma, 96 (69%) epithelioid subtype, 25 (18%) sarcomatoid, 9 (7%) biphasic, and 9 (7%) unclassified. They found no difference in frequency of volume loss between the groups, but noted that epithelioid type more commonly demonstrated a simple pleural effusion and sarcomatoid type more often presented as a focal mass. 16 In our study, we found that combined nonepithelioid subtypes are more likely to have calcified plaques than eMPM (P = 0.035). In addition, calcified pleural plaques seem more common in bMPM and sMPM when analyzed separately compared with eMPM, and internal mammary nodes were more common in sMPM. When stratified analysis accounting for differences in clinical stage was performed, both calcified plaques and local invasion were found to be more common in nonepithelioid subtype compared with eMPM (P = 0.057 and 0.045, respectively).
Our study is unique in obtaining histologic subtype classification primarily from surgical resection rather than less accurate techniques such as transthoracic biopsy in a large cohort of patients with this rare tumor. Open pleural biopsy is the most accurate sampling method and considered the criterion standard diagnosis of MPM. 18 All other pleural biopsy options are all less sensitive for determining histologic subtype, particularly nonepithelioid subtypes. One study reviewing patients who had undergone thoracotomy, thoracoscopy, or CT-guided procedure followed by extrapleural pneumonectomy found an overall subtype misclassification rate of 20%. 19 Image-guided transthoracic biopsy has the lowest accuracy in subtype classification (44%) when compared with thoracoscopy (74%) and thoracotomy (83%). 19 Open pleural biopsy demonstrates a sensitivity and specificity for epithelioid MPM of 97% and 56%, respectively. In contrast, the sensitivity and specificity of open pleural biopsy for nonepithelioid subtypes were 56% and 97%, respectively, and the positive and negative predictive values were 91% and 79%, respectively. 18 These studies demonstrate that preresection biopsy has a high rate of subtype misclassification, particularly for nonepithelioid subtypes, with open biopsy being notably more accurate than transthoracic image-guided biopsies. In our study, 100% of pathology diagnoses were obtained from a surgical procedure (as detailed in the results section); none were obtained by image-guided biopsies. Moreover, 67% of our patients underwent complete surgical resection by pleurectomy decortication or extrapleural pneumonectomy. This is in contrast to prior studies in which the vast majority of specimens were from either surgical biopsy or image-guided biopsies, thus introducing a probable higher rate of misclassification of histologic subtype. Because most studies are relatively small sample size, misclassification of patients can presumably have a significant effect on findings. We also excluded all patients with prior pleurodesis, which could alter CT findings.
It must be noted that CT is limited in its ability to predict lymph node involvement and can underestimate extent of disease in early chest wall involvement. However, ongoing work suggests volumetric CT may provide more accurate clinical staging. 20, 21 Positron emission tomography-CT has increased accuracy in detecting nodal metastases and occult extrathoracic metastases as well as for localizing metabolically active biopsy targets. In addition, preliminary data suggest that FDG avidity within epithelioid mesothelioma may help identify rare pleomorphic subtype, which has a poorer prognosis. 22 Magnetic resonance imaging (MRI) has been shown to be superior to CT in specifically detecting a single focus of chest wall invasion and in identifying invasion of the diaphragm or the endothoracic fascia. 3 One study by Gill et al in 2009 evaluated the use of diffusion-weighted MRI to distinguish between histologic subtypes and found apparent diffusion coefficient (ADC) values of epithelioid mesothelioma to be higher than those of sarcomatoid and biphasic, with the latter 2 histologies demonstrating similar ADC values. However, the authors point out that use of MRI in this patient population may be limited by inability to perform breath hold, which subjects the study to errors in ADC due to image misregistration. 2 The retrospective nature of our study and its relatively small sample size are inherent limitations, both of which could be overcome by larger prospective multiinstitutional studies. We also had a relatively small number of nonepithelioid MPM cases, although this is similar to the distribution in prior studies and reflecting the lower incidence of this subtype. From a statistical perspective, because of the exploratory and hypothesis-generating nature of the study, multiple testing was not used and P values lesser than 0.05 were considered significant, and thus the results need to be interpreted with caution and validated in future studies.
In summary, our study shows that calcified pleural plaques and local invasion are more common in nonepithelioid subtypes of MPM compared with eMPM. Prior studies have shown conflicting results as to whether the histologic subtypes of MPM can be reliably distinguished by CT characteristics. Our study is unique in obtaining histologic subtype classification primarily from surgical resection, which is more accurate. Accurate noninvasive identification of eMPM is clinically vital, not simply academic. These patients typically undergo surgery in the setting of aggressive trimodality therapy in the United States, whereas higher risk patients, particularly those with sMPM, are diverted to more experimental interventions. Accurate subtype classification allows surgeons and oncologists to confidently recommend the appropriate treatment pathway. Further studies with larger cohorts may be useful to confirm the use of CT characteristics in distinguishing epithelioid from nonepithelioid histologies.
